They develop test that gives results of coronavirus in 5 minutes

Mexico.- Scientists from the Oxford University they developed a proof rapid Covid-19 able to identify the coronavirus in less than five minute.

The specialists of the British institution reported today October 15 that this test could be used in massive tests at airports and companies.

SarsCoV-2, which causes the Covid-19 disease, continues to spread across the planet and so far there are more than 38.5 million people infected, while the global death toll is over one million, while that of the recovered exceeds 26.7 million people.

To detect the new coronavirus There are two types of screening tests available: viral tests and antibody tests. A viral indicates whether you currently have an infection, while an antibody could indicate whether you previously had an infection.

Since the pandemic of the Covid-19A wide variety of diagnostics have been launched on the market, however, few have been reliable.

Oxford University indicated that it hopes to begin development of the Quick test which would give the coronavirus results in 5 minutes in early 2021 to have it approved and available 6 months later.

Mexico will participate in rapid tests

The Pan American Health Organization (PAHO) reported this Friday, October 15, that Mexico will participate in a pilot program for the application of rapid antigen tests that in a matter of minute, detect the SarsCov-2 virus that causes Covid-19 disease.

Carissa F. Etienne, director of the organization, said that although this innovation cannot replace the molecular test of PCR, its application will favor marginalized populations, since it will be able to test a greater number of people, more quickly and with less cost.

He stressed that a further spread of the coronavirus can also be prevented, since the confirmation of the case will be obtained in minutes and consequently, the patient can be isolated immediately, and not for hours or days waiting for the result by PCR, and in the one that the patient – without knowing it – can infect more people.

Development of a coronavirus vaccine

The University of Oxford, together with the pharmaceutical company AstraZaneca, carries out clinical trials for the development of a vaccine against coronavirus.

In a document, the university said global trials of the drugmaker’s vaccine, which it is developing with Oxford researchers, were suspended on Sept. 6, after a British study participant had a serious side effect that was thought could be a spinal inflammatory disorder called transverse myelitis.

He explained that the safety reviews began when volunteers of the vaccine candidate, called AZD1222 or ChAdOx1 nCoV-19, developed unexplained neurological symptoms that included limb weakness or changes in sensation.

With information from Reuters